Rasheed Onafuye
Geriatric Psychiatry · Monroe, NCNPI 1669651667
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,822 of the $2,695 with a category attached, or 67.6%. Neuronetics, Inc. accounts for 71.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $1,883 and has fallen 81.9% since, to $341 in 2025.
Across 32 payments — averaging $84.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$2K
- Amgen$242
- Johnson & Johnson$106
- Supernus Pharmaceuticals, Inc.$95
- AbbVie$86
- Otsuka America Pharmaceutical, Inc.$61
- plus $185 from 6 others
Across 406 payments — averaging $7873.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Indivior Inc.$3M
- Janssen Research & Development, LLC$111K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$52K
- AbbVie$7K
What the payments were for
- Travel & lodging$87332%
- Food & beverage$1,82268%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 6 | $1,922 |
| Amgen(2 entities) | 2 | $242 |
| Johnson & Johnson | 4 | $106 |
| Supernus Pharmaceuticals, Inc. | 2 | $95 |
| AbbVie(2 entities) | 5 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $40 |
| Lundbeck LLC | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Indivior Inc. | 1 | $27 |
| Neos Therapeutics, LP | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$1,823
- KRYSTEXXA$242
How this compares
Too few geriatric psychiatry providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine Hcl | 70 | $3,670 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $1,178 |
| Fluoxetine Hcl | 46 | $683 |
| Clonazepam | 61 | $501 |
| Lamotrigine | 31 | $269 |
| Bupropion Hcl SrBupropion Hcl | 18 | $167 |
| Zolpidem Tartrate | 17 | $157 |
| Temazepam | 12 | $154 |
| Alprazolam | 16 | $153 |
| Gabapentin | 13 | $75 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $72 |
| Diazepam | 14 | $68 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $45 |
| Topiramate | 12 | $44 |
| Trazodone Hcl | 15 | $43 |
Paid to pharmacies, not to this prescriber.
Other geriatric psychiatry in Monroe
- Christopher McKinleyLeland$9K
- Kurian AbrahamCharlotte$7K
- Michael LangGreenville$2K
- Matthew KernWinston Salem$367
- Aaron BrodskyHendersonville$266
- Rhonda StahlRaleigh$165
- Tracey HolsingerDurham$100
- Robert WilliamsDurham$78
- Jill HeathAsheville$77
- Mary LunsfordChapel Hill$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.